心衰患者利尿剂抵抗的研究进展
Research Progress of Diuretic Resistance in Patients with Heart Failure
DOI: 10.12677/ACM.2018.810158, PDF,   
作者: 万秋华：云南省阜外心血管病医院，云南 昆明
关键词: 慢性心力衰竭；利尿剂抵抗；研究进展；Chronic Heart Failure； Diuretic Resistance； Research Progress
摘要: 利尿剂是一个能明确改善心衰症状的药物，在心衰治疗中占有无可替代的地位。利尿剂的合理使用是其他药物治疗心力衰竭成功的基石。心衰患者利尿剂使用举足重轻，常常贯穿心衰治疗的始终。长期应用利尿剂的慢性严重心衰患者中，发生利尿剂抵抗比较常见，发生率约为1/3。
Abstract: Diuretics are a drug that can definitely improve the symptoms of heart failure and play an irre-placeable role in the treatment of heart failure. Rational use of diuretics is the cornerstone of suc-cessful treatment of heart failure with other drugs. Diuretics are very important in the treatment of heart failure, and often used throughout the treatment of heart failure. Diuretic resistance is common in patients with chronic severe heart failure who use diuretics for a long time. The inci-dence is about 1/3.
文章引用：万秋华. 心衰患者利尿剂抵抗的研究进展[J]. 临床医学进展, 2018, 8(10): 953-957. https://doi.org/10.12677/ACM.2018.810158

参考文献

[1] 卫杏利, 王少黎, 邢玉平. 现代心衰药物治疗回顾[J]. 中华医史杂志, 2017, 47(1): 60.
[2] 毛威, 陈晨. 急性失代偿性心力衰竭时利尿剂抵抗的对策[J]. 心电与循环, 2018, 37(2): 86-95.
[3] Aronson, D. and Burger, A.J. (2016) Diuretic Response: Clinical and Hemodynamic Predictors and Relation to Clinical Outcome. Journal of Cardiac Failure, 22, 193-200. [Google Scholar] [CrossRef] [PubMed]
[4] Verbrugge, F.H., Mullens, W. and Tang, W.H. (2016) Management of Cardio-Renal Syndrome and Diuretic Resistance. Current Treatment Options in Cardiovascular Medicine, 18, 11. [Google Scholar] [CrossRef] [PubMed]
[5] 张瑜. 慢性心力衰竭患者的利尿剂抵抗及其处理策略[J]. 饮食保健, 2018, 5(13): 122.
[6] Hanberg, J.S., Rao, V., Maaten, J.M.T., et al. (2016) Hypochloremia and Diuretic Resistance in Heart Failure: Mechanistic Insights. Circulation Heart Failure, 9, S8-S8. [Google Scholar] [CrossRef] 
[7] Shah, N., Madanieh, R., Alkan, M., et al. (2017) A Perspective on Diuretic Resistance in Chronic Congestive Heart Failure. Therapeutic Advances in Cardiovascular Disease, 11, 271-278. [Google Scholar] [CrossRef] [PubMed]
[8] 杨成念. 心力衰竭患者利尿剂抵抗治疗研究进展[J]. 现代医药卫生, 2017, 33(22): 3432-3434.
[9] 王立立, 耿彦平, 杨倩, 等. 托伐普坦联合呋塞米治疗老年慢性心力衰竭利尿剂抵抗患者的疗效观察[J]. 中华老年心脑血管病杂志, 2018, 20(2): 158-160.
[10] 杨艳, 胡田喜. 重组人脑利钠肽改善慢性心力衰竭利尿剂抵抗临床研究[J]. 中国药业, 2018, 27(4): 41-43.
[11] 胡媛媛, 朱永锋, 刘景瑞, 等. 托拉塞米联合低浓度多巴胺治疗老年心力衰竭利尿剂抵抗的临床价值分析[J]. 中国医药指南, 2017, 15(16): 29-30.
[12] 杨国文, 杨杨. 利尿剂抵抗性心力衰竭应用呋塞米联合多巴胺持续静脉泵入治疗的临床观察[J]. 临床医药文献杂志, 2017, 4(96): 18818-18819.
[13] 汪勇. 大剂量利尿剂在伴有利尿剂抵抗心力衰竭患者中的应用疗效观察[J]. 中国实用医药, 2016, 11(26): 227-228.
[14] 杜锦权. 前列地尔联合利尿剂在慢性心力衰竭伴利尿剂抵抗中的临床疗效分析[J]. 检验医学与临床, 2015, 12(16): 2450-2452.
[15] 陈智杰. 血液超滤治疗利尿剂抵抗急性失代偿性心力衰竭的临床疗效[J]. 心血管病防治知识, 2017(5): 66-67.

为你推荐